Form 4: Amgen Director Michael V. Drake Reports Acquisition of Common Stock

Director Michael V. Drake reports acquiring Amgen common stock through vested Restricted Stock Units and dividend equivalents.

Summary

• On August 9, 2024, Michael V. Drake, a director of Amgen Inc., reported acquiring 108.5305 shares of common stock.
• The acquisition was a result of vested Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The RSUs vested immediately and are payable in shares of Amgen's common stock on a one-to-one basis.
• The reported transaction also includes 116 Dividend Equivalents (DEs) granted pursuant to the Director Program.
• Following the transaction, Drake beneficially owns 3,307.2967 shares of Amgen common stock.

Sentiment

Score: 7

Explanation: Director acquiring shares is generally a positive sign, indicating confidence in the company's future performance. The transaction is part of a standard compensation plan.

Positives

• The acquisition of shares by a director signals confidence in the company.
• The vesting of RSUs and dividend equivalents indicates continued participation in Amgen's incentive programs.

Future Outlook

The director has the option to defer payment of the vested RSUs, which would affect the timing of share distribution.

Industry Context

Director share acquisitions are common and often tied to compensation and incentive programs, reflecting alignment with shareholder interests.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.
• The vesting of RSUs and dividend equivalents incentivizes the director to act in the best interests of the company and its shareholders.

Key Dates